These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 10325506)
1. Chemoprevention of hormone-dependent prostate cancer in the Wistar-Unilever rat. McCormick DL; Rao KV Eur Urol; 1999; 35(5-6):464-7. PubMed ID: 10325506 [TBL] [Abstract][Full Text] [Related]
2. Chemoprevention of rat prostate carcinogenesis by 9-cis-retinoic acid. McCormick DL; Rao KV; Steele VE; Lubet RA; Kelloff GJ; Bosland MC Cancer Res; 1999 Feb; 59(3):521-4. PubMed ID: 9973192 [TBL] [Abstract][Full Text] [Related]
3. Chemoprevention of rat prostate carcinogenesis by early and delayed administration of dehydroepiandrosterone. Rao KV; Johnson WD; Bosland MC; Lubet RA; Steele VE; Kelloff GJ; McCormick DL Cancer Res; 1999 Jul; 59(13):3084-9. PubMed ID: 10397249 [TBL] [Abstract][Full Text] [Related]
4. Null activity of selenium and vitamin e as cancer chemopreventive agents in the rat prostate. McCormick DL; Rao KV; Johnson WD; Bosland MC; Lubet RA; Steele VE Cancer Prev Res (Phila); 2010 Mar; 3(3):381-92. PubMed ID: 20145190 [TBL] [Abstract][Full Text] [Related]
5. Influence of N-methyl-N-nitrosourea, testosterone, and N-(4-hydroxyphenyl)-all-trans-retinamide on prostate cancer induction in Wistar-Unilever rats. McCormick DL; Rao KV; Dooley L; Steele VE; Lubet RA; Kelloff GJ; Bosland MC Cancer Res; 1998 Aug; 58(15):3282-8. PubMed ID: 9699656 [TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of rat prostate carcinogenesis by dietary 16alpha-fluoro-5-androsten-17-one (fluasterone), a minimally androgenic analog of dehydroepiandrosterone. McCormick DL; Johnson WD; Kozub NM; Rao KV; Lubet RA; Steele VE; Bosland MC Carcinogenesis; 2007 Feb; 28(2):398-403. PubMed ID: 16952912 [TBL] [Abstract][Full Text] [Related]
7. Chemopreventive activity of tamoxifen, N-(4-hydroxyphenyl)retinamide, and the vitamin D analogue Ro24-5531 for androgen-promoted carcinomas of the rat seminal vesicle and prostate. Lucia MS; Anzano MA; Slayter MV; Anver MR; Green DM; Shrader MW; Logsdon DL; Driver CL; Brown CC; Peer CW Cancer Res; 1995 Dec; 55(23):5621-7. PubMed ID: 7585644 [TBL] [Abstract][Full Text] [Related]
8. Chemoprevention of rat prostate carcinogenesis by soy isoflavones and by Bowman-Birk inhibitor. McCormick DL; Johnson WD; Bosland MC; Lubet RA; Steele VE Nutr Cancer; 2007; 57(2):184-93. PubMed ID: 17571952 [TBL] [Abstract][Full Text] [Related]
9. Null effect of dietary restriction on prostate carcinogenesis in the Wistar-Unilever rat. McCormick DL; Johnson WD; Haryu TM; Bosland MC; Lubet RA; Steele VE Nutr Cancer; 2007; 57(2):194-200. PubMed ID: 17571953 [TBL] [Abstract][Full Text] [Related]
11. 2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice. Green JE; Shibata MA; Shibata E; Moon RC; Anver MR; Kelloff G; Lubet R Cancer Res; 2001 Oct; 61(20):7449-55. PubMed ID: 11606379 [TBL] [Abstract][Full Text] [Related]
12. Use of animal models in defining efficacy of chemoprevention agents against prostate cancer. Bosland MC Eur Urol; 1999; 35(5-6):459-63. PubMed ID: 10325505 [TBL] [Abstract][Full Text] [Related]
13. 9-cis-retinoic acid but not 4-(hydroxyphenyl)retinamide inhibits prostate intraepithelial neoplasia in Noble rats. Christov KT; Moon RC; Lantvit DD; Boone CW; Steele VE; Lubet RA; Kelloff GJ; Pezzuto JM Cancer Res; 2002 Sep; 62(18):5178-82. PubMed ID: 12234981 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of rat mammary gland chemical carcinogenesis by dietary dehydroepiandrosterone or a fluorinated analogue of dehydroepiandrosterone. Ratko TA; Detrisac CJ; Mehta RG; Kelloff GJ; Moon RC Cancer Res; 1991 Jan; 51(2):481-6. PubMed ID: 1824682 [TBL] [Abstract][Full Text] [Related]
15. Chemoprevention of rat prostate carcinogenesis by diallyl disulfide, an organosulfur compound of garlic. Arunkumar A; Vijayababu MR; Venkataraman P; Senthilkumar K; Arunakaran J Biol Pharm Bull; 2006 Feb; 29(2):375-9. PubMed ID: 16462049 [TBL] [Abstract][Full Text] [Related]
16. Prevention of primary prostate cancer in Lobund-Wistar rats by N-(4-hydroxyphenyl)retinamide. Pollard M; Luckert PH; Sporn MB Cancer Res; 1991 Jul; 51(13):3610-1. PubMed ID: 1829024 [TBL] [Abstract][Full Text] [Related]
17. Induction of dorsolateral prostate adenocarcinomas and other accessory sex gland lesions in male Wistar rats by a single administration of N-methyl-N-nitrosourea, 7,12-dimethylbenz(a)anthracene, and 3,2'-dimethyl-4-aminobiphenyl after sequential treatment with cyproterone acetate and testosterone propionate. Bosland MC; Prinsen MK Cancer Res; 1990 Feb; 50(3):691-9. PubMed ID: 2137026 [TBL] [Abstract][Full Text] [Related]
18. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials. Greenwald P J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595 [TBL] [Abstract][Full Text] [Related]
19. Characterization of adenocarcinomas of the dorsolateral prostate induced in Wistar rats by N-methyl-N-nitrosourea, 7,12-dimethylbenz(a)anthracene, and 3,2'-dimethyl-4-aminobiphenyl, following sequential treatment with cyproterone acetate and testosterone propionate. Bosland MC; Prinsen MK; Dirksen TJ; Spit BJ Cancer Res; 1990 Feb; 50(3):700-9. PubMed ID: 2105161 [TBL] [Abstract][Full Text] [Related]
20. Persistence of prostatic intraepithelial neoplasia after effective chemoprevention of microscopic prostate cancer with antiandrogen in a rat model. Yamauchi A; Kawai K; Tsukamoto S; Ideyama Y; Shirai T; Akaza H J Urol; 2006 Jan; 175(1):348-52. PubMed ID: 16406940 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]